Dr. Samuel Paul Haslam, MD

Dr. Haslam practices at UCLA Medical Plaza in Los Angeles, California.

Dr. Haslam's NPI, 1346777570, was assigned on May 18, 2017. Dr. Haslam graduated from UTMB Health in 2017. Dr. Haslam holds California license A184861.

Dr. Haslam's primary practice is UCLA Medical Plaza, at 5767 W Century Blvd, Los Angeles, CA 90045 in Los Angeles County. The practice phone is (310) 794-1276.

Dr. Haslam's primary practice is UCLA Medical Plaza in Los Angeles, California. Dr. Haslam is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Haslam to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Haslam practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Haslam's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Haslam is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Haslam is licensed in California.

Dmand AI lists acute respiratory failure, asthma, chronic obstructive pulmonary disease (COPD), chronic respiratory failure and tobacco use among the conditions Dr. Haslam treats.

CMS data shows 2,345 Medicare services from Dr. Haslam across 16 procedure codes in 2024, for 701 Medicare patients. Medicare paid $179,179 for them.

CMS counts 701 Medicare patients who saw Dr. Haslam in 2024. The largest group is 75 to 84, with 291 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Haslam's median patient age at 69, with 57% women.

In 2024, Dr. Haslam wrote 1,461 Medicare Part D claims for 303 patients. CMS names the drug for 1,266 of them, across 26 drugs with 11 or more claims each, at $423,657 in total drug cost. In 2023, CMS named 79 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Haslam for performance year 2024, reported as part of a group. Dr. Haslam accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Haslam as offering telehealth.

CMS Open Payments shows 10 general payments to Dr. Haslam from 9 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 71% of the total. Verona Pharma, Inc. paid the most, $125.

Dr. Haslam graduated from UTMB Health in 2017.

Dr. Haslam is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.